Base by Base

Guyon L et al., Nature Communications - Forward-time simulations and coalescent inference show that variance in reproductive success among patrilineal descent groups combined with lineal fission can produce the observed post‑Neolithic decline in male effective population size (Y chromosome) without requiring large-scale intermale violence. Key terms: patrilineality, Y-chromosome bottleneck, population genetics, SLiM simulations, social structure.

Study Highlights:
The authors used SLiM forward-time socio-demographic simulations with tree-sequence recording, π-based diversity measures, and Bayesian skyline plots (BEAST) to compare bilateral and patrilineal scenarios with random or lineal fission, group growth variance, migration and modeled violence. They find that variance in reproductive success between patrilineal groups together with lineal fission is sufficient to drive a large reduction in male effective population size while female Ne continues to grow. Violence modeled as high male mortality produces a faster but smaller long-term effect than group-level reproductive variance, and polygyny alone is insufficient to reproduce the observed bottleneck. Timing analyses show that transitions in kinship systems linked to agro-pastoral shifts can produce bottlenecks compatible with archaeological dates.

Conclusion:
A shift toward segmentary patrilineal social organization — characterized by lineal fission and intergroup variance in reproductive success associated with the rise of agro‑pastoralism — can explain the post‑Neolithic Y‑chromosome bottleneck without invoking pervasive ancient violence.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
Patrilineal segmentary systems provide a peaceful explanation for the post‑Neolithic Y‑chromosome bottleneck

First author:
Guyon L

Journal:
Nature Communications

DOI:
10.1038/s41467-024-47618-5

Reference:
Guyon L, Guez J, Toupance B, Heyer E, Chaix R. Patrilineal segmentary systems provide a peaceful explanation for the post‑Neolithic Y‑chromosome bottleneck. Nature Communications. 2024;15:3243. doi:10.1038/s41467-024-47618-5

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/patrilineal-segmentary-systems-and-the-postneolithic-ychromosome-bottleneck

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-09-27.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited the transcript sections that explain the Y-chromosome bottleneck, the peaceful patrilineal/segmentary hypothesis, model design (patrilocal residence, patrilineal descent, lineal vs random fission, variance in reproductive success), polygyny tests, simulation methods (SLiM), diversity measures (π-based) and BEAS
- transcript topics: Y-chromosome bottleneck timing and regional variation; patrilineal segmentary systems and peaceful explanation; lineal vs random descent/fission; patrilocal residence and female/male migration; variance in reproductive success and wealth transmission; polygyny tests and their impact on diversity

QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 7
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- Post-Neolithic Y-chromosome bottleneck occurred worldwide around 3,000–5,000 years ago; female Ne increased.
- Violence alone cannot explain the Y-chromosome bottleneck; a peaceful explanation is possible.
- Lineal (patrilineal) fission combined with variance in reproductive success reduces male Ne; lineal fission more effective than random fission.
- Polygyny alone reduces male Ne but is insufficient to account for the magnitude of the bottleneck (roughly 4x in a hyper-polygyny model).
- π-based and BEAST skyline plots provide complementary estimates; female-to-male Ne ratio can reach very high values (up to ~29.4 in some scenarios).
- Timing of the bottleneck is compatible with the rise of agro-pastoralism and shifts in kinship systems; explicit violence is not required.

QC result: Pass.

Kivisild T et al., Hum Genet (2017) 136:529–546 - Review of how high-throughput sequencing of ancient human remains has enabled genome-scale study of male-specific Y chromosome variation, the methodological challenges of working with ancient Y data, and examples of regional continuity and turnover in Y haplogroups across Eurasia and the Americas. Key terms: ancient DNA, Y chromosome, haplogroups, population history, high-throughput sequencing.

Study Highlights:
High-throughput sequencing and capture methods now allow recovery of ancient Y chromosome sequences but face challenges from low endogenous DNA, post-mortem damage, repetitive Y regions and ascertainment bias of SNP-capture panels. Shotgun sequencing is preferred where human DNA content is high, while capture approaches increase overlapping SNP coverage but cannot discover novel variants. Ancient Y sequences from late Pleistocene and Holocene Eurasia map to major non-African founding lineages and reveal shifts in haplogroup composition through the Neolithic and Bronze Age, notably later expansions of R1a/R1b. Ancient American Y data confirm early presence of Q and C lineages and show distinct Palaeo-Eskimo Q sub-clades.

Conclusion:
Ancient Y chromosome data complement autosomal and mitochondrial evidence by revealing male-lineage continuity and turnover across time and space, but robust inference requires attention to damage, coverage, repeat regions and ascertainment bias and broader sampling from underrepresented regions.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
The study of human Y chromosome variation through ancient DNA

First author:
Kivisild T

Journal:
Hum Genet (2017) 136:529–546

DOI:
10.1007/s00439-017-1773-z

Reference:
Kivisild T. The study of human Y chromosome variation through ancient DNA. Hum Genet (2017) 136:529–546. DOI 10.1007/s00439-017-1773-z

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/cultural-hitchhiking-and-the-postneolithic-ychromosome-bottleneck

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-09-26.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited the transcript's coverage of ancient Y chromosome sequencing methods, damage authentication, and major demographic inferences (Europe, the Americas), plus Native American and Paleo-Eskimo lineages as described in the article.
- transcript topics: HTS challenges for ancient Y chromosome (repeats and X-Y homology); Shotgun sequencing vs capture-based enrichment; Damage authentication via end-of-read C to T patterns; Y-chromosome haplogroup history in ancient Europe (G, H, I, J, R1a/R1b, C); Bronze Age Yamnaya migrations and male-biased turnover; Native American Y-chromosome lineages Q and C and Malta Boy dual ancestry

QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 7
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- DOI in metadata matches the canonical article DOI
- Article title in metadata matches the canonical article title
- Article journal in metadata matches the canonical journal citation
- License in metadata matches the article's CC BY 4.0 variant

QC result: Pass.

Sanoguera-Miralles L et al., Clinical Chemistry - This episode examines a minigene-based functional study of 52 CHEK2 splice-site variants from the BRIDGES project, reporting widespread splice disruption, characterization of 89 transcripts, and an ACMG/AMP-informed tentative clinical classification. Key terms: CHEK2, splicing, minigene assay, variant classification, breast cancer.

Study Highlights:
The authors selected 52 candidate splice-site variants from 128 intron–exon boundary changes and tested them in three validated CHEK2 minigenes in MCF-7 cells. Forty-six variants (88.5%) impaired splicing and 34 produced negligible full-length transcript, generating a total of 89 different transcripts of which 59 are predicted to introduce premature termination codons. They identified complex outcomes including multi-exon skipping, cryptic site usage and a rare noncanonical TG acceptor activated by c.684-2A>G, and incorporated minigene read-outs into an ACMG/AMP-based point system to tentatively classify variants. The workflow allowed classification of 27 pathogenic/likely pathogenic and 5 likely benign variants, while 20 remained variants of uncertain significance.

Conclusion:
Minigene assays revealed high spliceogenicity among selected CHEK2 variants and, when combined with a modified ACMG/AMP framework, provided tentative clinical classifications but left a substantial fraction (38%) as VUSs, highlighting the need for complementary case-control, family, or patient RNA data.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants

First author:
Sanoguera-Miralles L

Journal:
Clinical Chemistry

DOI:
10.1093/clinchem/hvad125

Reference:
Sanoguera-Miralles L, Valenzuela-Palomo A, Bueno-Martínez E, Esteban-Sánchez A, Lorca V, Llinares-Burguet I, García-Álvarez A, Pérez-Segura P, Infante M, Easton DF, Devilee P, Vreeswijk MPG, de la Hoya M, Velasco-Sampedro EA. Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants. Clinical Chemistry. 2024;70(1):319–338. doi:10.1093/clinchem/hvad125

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/systematic-minigene-based-splicing-analysis-and-tentative-clinical-classification-of-52-chek2-splice-site-variants

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-09-25.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited the spoken content for accuracy of core methods, results, and clinical implications of the CHEK2 minigene splicing analysis, including variant selection, three-minigene design, splicing outcomes, TG acceptor discovery, ACMG/AMP classification, and clinical impact; noted minor terminology variations.
- transcript topics: CHEK2 splicing and cancer risk; Minigene methodology and experimental design; Bioinformatic filtering and variant prioritization; Splicing outcomes and transcript diversity (89 transcripts, 59 with PTCs); ACMG/AMP-based tentative classification (32 variants; 27 P/LP, 5 LB; 20 VUS); Notable c.684-2A>G TG acceptor activation and exon 6 enhancers

QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 6
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- 52 CHEK2 splice-site variants were analyzed in minigenes (from BRIDGES dataset).
- Three CHEK2 minigenes spanning all 15 exons were used for assays.
- 46 of 52 variants (88.5%) disrupted splicing; 34 produced negligible full-length transcript.
- 89 distinct transcripts were observed across variants; 59 predicted to introduce premature termination codons.
- 32 variants were tentatively classified by ACMG/AMP framework: 27 pathogenic/likely pathogenic, 5 likely benign; 20 remained VUS.
- Variant c.684-2A>G activated a noncanonical TG acceptor site, with exon 6 enhancers influencing recognition.

QC result: Pass.

Ying Y et al., Clinical Chemistry 71:4 (2025) 510–519 - This episode reviews a Clinical Chemistry study that developed an improved one-step ultra-long-range PCR with PCR suppression primers and PacBio SMRT long-read sequencing to obtain 26.1 kb full-length ABO haplotypes from the 5′ UTR to the 3′ UTR, enabling comprehensive allele annotation and resolution of complex ABO variants. Key terms: ABO, haplotype sequencing, long-read sequencing, structural variants, 3' UTR.

Study Highlights:
The authors amplified a 26.1 kb full-length ABO amplicon using an improved one-step ultra-long-range PCR with PCR suppression primers and generated phased haplotypes by PacBio SMRT sequencing. They analyzed 158 haplotypes from 79 blood donors and 47 variant specimens, identifying coding, intronic, promoter, UTR, and structural variants. The work revealed allele-specific intron 1 (TA)n VNTR patterns, detailed 5′ and 3′ UTR motif/unit structures, and resolved large SVs including a 7337 bp deletion in an erythroid enhancer, recombinants, and chimeras. The method outperformed PCR-SBT and short-read NGS for phasing and SV detection but requires high-quality DNA and limited UTR/intronic validation by secondary methods.

Conclusion:
Full-length ABO haplotype sequencing spanning 5′ to 3′ UTR fills reference gaps, refines allele sequence patterns, and improves detection and resolution of structural and regulatory variants relevant to transfusion and transplantation; practical use is powerful but constrained by DNA quality and limited orthogonal validation for some noncoding variants.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
Comprehensive Annotation of Complete ABO Alleles and Resolution of ABO Variants by an Improved Full-Length ABO Haplotype Sequencing

First author:
Ying Y

Journal:
Clinical Chemistry 71:4 (2025) 510–519

DOI:
10.1093/clinchem/hvaf015

Reference:
Ying Y, Zhang J, Hong X, Yuan W, Ma K, Huang X, Xu X, Zhu F. Comprehensive Annotation of Complete ABO Alleles and Resolution of ABO Variants by an Improved Full-Length ABO Haplotype Sequencing. Clinical Chemistry. 2025;71(4):510-519. doi:10.1093/clinchem/hvaf015

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/comprehensive-annotation-of-complete-abo-alleles-and-resolution-of-abo-variants

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-09-24.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited the transcript sections describing (1) end-to-end ABO haplotype sequencing from 5' UTR to 3' UTR, (2) ultra-long-range PCR with PCR suppression, (3) PacBio SMRT sequencing and haplotype phasing, (4) haplotype patterning and structural variations including deletions, recombination, and chimeras, and (5) clinical
- transcript topics: Full-length ABO haplotype sequencing (5' UTR to 3' UTR); Ultra-long-range PCR with PCR suppression; PacBio SMRT sequencing and CCS/pbmm2 analysis; Intron 1 TA VNTR and 5' UTR minisatellites; 3' UTR unit mapping (units 1–14) and NG_006669.2 comparison; Structural variations: deletions, recombination, chimeras

QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 7
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- 26.1 kb full-length ABO haplotype amplicon with no splicing
- 158 haplotypes from 79 donors and 47 ABO variants
- Dominant alleles A1.01, A1.02, B.01, O.01.01, O.01.02; two rare alleles A2.05 and O.01.71
- TA VNTR in intron 1; median TA repeats: 21 for A1.02 and B.01; 13 for O alleles
- 5' UTR minisatellite motifs and 3' UTR units 1–14; NG_006669.2 lacks units 11–13
- 7337 bp deletion in an erythroid enhancer associated with Bel phenotype

QC result: Pass.

Chan HT et al et al., Clinical Chemistry - This study evaluates an automated, decentralized cfDNA NGS workflow (Oncomine Precision Assay GX with the Genexus system) in 298 patients with advanced solid tumors. The assay achieved 99% sequencing success, detected mut-ctDNA in about half of patients, identified actionable or resistance alterations in 18% of patients, and showed 72% concordance with matched tissue profiling. Detection sensitivity varied by cancer type, tumor burden, and metastatic site, and plasma-only variants were enriched after targeted therapy. Key terms: cell-free DNA, ctDNA, decentralized sequencing, Oncomine Precision Assay, liquid biopsy.

Study Highlights:
An automated point-of-care cfDNA NGS workflow yielded a 99% sequencing success rate and higher success than archived tissue. Approximately 50% of patients had detectable mut-ctDNA and 18% harbored targetable or resistance alterations, with overall tissue–plasma concordance of 72%. Plasma-only alterations (63 events) were found in 18% of patients and were more frequent after targeted therapy; detection sensitivity correlated with tumor fraction, lesion size, cancer type, and metastatic site. Clonal hematopoiesis and limited gene coverage of the assay were notable confounders.

Conclusion:
Automated, decentralized cfDNA genomic profiling is clinically feasible and can expand timely access to actionable genomic data, but results should be interpreted considering tumor burden, metastatic site, prior therapies, and clonal hematopoiesis.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
Automated and Decentralized Genomic Profiling of Plasma Cell-Free DNA for Identification of Targetable and Resistance Alterations in Advanced Solid Tumors

First author:
Chan HT et al

Journal:
Clinical Chemistry

DOI:
10.1093/clinchem/hvaf045

Reference:
Chan HT et al. Automated and Decentralized Genomic Profiling of Plasma Cell-Free DNA for Identification of Targetable and Resistance Alterations in Advanced Solid Tumors. Clinical Chemistry 71:6 700–712 (2025). https://doi.org/10.1093/clinchem/hvaf045

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/automated-and-decentralized-genomic-profiling-of-plasma-cell-free-dna-in-solid-tumors

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-09-23.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited transcript sections describing the decentralized cfDNA workflow (OPA GX + Genexus), matched-normal CH filtering, plasma–tissue concordance, cancer-type shedding differences, plasma-only alterations, and complementary tissue testing.
- transcript topics: Foundations of cfDNA/ctDNA and liquid biopsy; Decentralized cfDNA sequencing workflow (OPA GX + Genexus); Clonal hematopoiesis and matched normal filtering; Plasma–tissue concordance and determinants (tumor burden and metastatic site); Plasma-only alterations and resistance evolution; Complementary role of tissue testing and limits of plasma CNV detection

QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 7
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- Study cohort of 298 patients with advanced solid tumors; comparison between automated decentralized cfDNA NGS (OPA GX + Genexus) and FoundationOne CDx tissue profiling
- cfDNA sequencing success: 99%; tissue sequencing success: 96%
- Mut-ctDNA detected in 49.5% after exclusion of clonal hematopoiesis (CH) and germline alterations
- 63 plasma-only alterations identified in 18% of patients
- Overall plasma–tissue concordance: 72%
- Concordance by metastatic site: liver metastases 84.2%, lung metastases 41.5%

QC result: Pass.

Marín F et al., Clinical Chemistry - This episode examines a validation study of a highly sensitive NGS-based microsatellite instability (hs-MSI) assay for diagnosing constitutional mismatch repair deficiency (CMMRD). The assay was tested on blinded blood cohorts and CMMRD-associated tumors, compared with a low-pass whole-genome LOGIC/MMRDness score, and evaluated for gene-specific MSI indel patterns that identify PMS2 biallelic carriers. Key terms: microsatellite instability, CMMRD, PMS2, hs-MSI assay, genetic diagnostics.

Study Highlights:
The hs-MSI assay was validated in blinded blood and tumor cohorts with very high accuracy for CMMRD detection (sensitivity ~98.5% and specificity 100%). Hs-MSI scores correlated strongly with LOGIC/MMRDness scores (r = 0.89 in blood, r = 0.82 in tumors). Analysis of indel allele distributions distinguished biallelic PMS2 pathogenic variant carriers with an accuracy of 0.997 and higher hs-MSI scores associated with younger age at first tumor diagnosis (r = −0.43).

Conclusion:
The hs-MSI assay is an accurate ancillary diagnostic tool for CMMRD that can detect MSI in blood and tumors and help pinpoint PMS2 as the affected germline gene.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
A Validated Highly Sensitive Microsatellite Instability Assay Accurately Identifies Individuals Harboring Biallelic Germline PMS2 Pathogenic Variants in Constitutional Mismatch Repair Deficiency

First author:
Marín F

Journal:
Clinical Chemistry

DOI:
10.1093/clinchem/hvae027

Reference:
Marín F, Canet-Hermida J, Bianchi V, et al. A Validated Highly Sensitive Microsatellite Instability Assay Accurately Identifies Individuals Harboring Biallelic Germline PMS2 Pathogenic Variants in Constitutional Mismatch Repair Deficiency. Clinical Chemistry. 2024;70(5):737–746. doi:10.1093/clinchem/hvae027

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/a-validated-highly-sensitive-microsatellite-instability-assay-identifies-pms2-variants-in-cmmrd

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-09-22.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited sections cover the hs-MSI assay development, 192-marker MSI panel, comparison with LOGIC/MMRDness, indel signatures distinguishing PMS2 carriers, performance metrics (sensitivity/specificity), cross-tissue detection (blood and tumor), and clinical implications for therapy and surveillance.
- transcript topics: Constitutional mismatch repair deficiency (CMMRD) overview; PMS2 gene, pseudogenes, and diagnostic challenges; highly sensitive MSI (hs-MSI) assay development; 192-microsatellite panel versus LOGIC/MMRDness; indel (insertion/deletion) signatures by affected gene; PMS2 signature as diagnostic marker (0.997 accuracy)

QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 6
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- hs-MSI uses a panel of 192 microsatellites; threshold 4.57% used to call positive MSI status
- blood-based hs-MSI detected CMMRD with ~98.5% sensitivity and 100% specificity
- hs-MSI scores correlated with LOGIC/MMRDness scores (r = 0.89 in blood; r = 0.82 in tumors)
- PMS2 carriers show a distinctive indel signature with higher insertions; overall PMS2-indel accuracy 0.997
- hs-MSI detected MSI in all 24 tumor samples analyzed (across multiple organ origins)
- higher hs-MSI scores in blood correlated with younger age at first tumor (r = -0.43)

QC result: Pass.

Poszewiecka B et al., BMC Genomics (2022) 23:616 - This study presents an improved algorithm to compute the UBCS statistic and uses it to re-estimate the timing of the ancestral fusion that formed human chromosome 2, comparing human and Great Ape genomes. Key terms: human chromosome 2, chromosomal fusion, biased gene conversion, UBCS statistic, Great Apes evolution.

Study Highlights:
The authors developed an enhanced algorithm that uses inclusion–exclusion and dynamic programming to compute the Unexpected Bias Clustered Substitutions (UBCS) statistic exactly for complex intersecting clusters. Applying this method to human and Great Ape genomes, they estimate the HSA2 fusion occurred ~0.9 Mya with a 95% CI of 0.4–1.5 Mya. The UBCS proportion also tracked evolutionary distances across chimpanzee, bonobo, gorilla, orangutan and gibbon, supporting its use in speciation timing. Differences in some estimates (e.g., bonobo) were attributed to genome assembly quality and local mutational dynamics.

Conclusion:
An improved UBCS computation revises the HSA2 fusion estimate to about 0.9 Mya and demonstrates that biased clustered substitutions near telomeres can inform relative speciation timing among Great Apes.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
Revised time estimation of the ancestral human chromosome 2 fusion

First author:
Poszewiecka B

Journal:
BMC Genomics (2022) 23:616

DOI:
10.1186/s12864-022-08828-7

Reference:
Poszewiecka B, Gogolewski K, Stankiewicz P, Gambin A. Revised time estimation of the ancestral human chromosome 2 fusion. BMC Genomics. 2022;23:616. doi:10.1186/s12864-022-08828-7

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/revised-time-estimation-of-the-ancestral-human-chromosome-2-fusion

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-09-21.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited portions covering the chromosome 2 fusion event, Biased Gene Conversion and UBCS, the improved inclusion–exclusion/dynamic programming method, the fusion date estimation, Great Ape divergence times, bonobo assembly caveats, and proposed future directions.
- transcript topics: Chromosome 2 fusion event and telomere signatures; Biased gene conversion and UBCS statistics; Algorithmic advance: inclusion–exclusion and dynamic programming; Fusion date estimation for HSA2 (~0.9 Mya) and CI; Great Ape speciation distances inferred from UBCS; Bonobo assembly quality and date discrepancy

QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 7
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- Enhanced algorithm for exact calculation of UBCS using inclusion–exclusion and dynamic programming
- HSA2 fusion date estimated at ~0.9 million years ago with 95% CI 0.4–1.5 Mya
- Bonobo-Homo fusion date estimated at ~0.67 Mya with CI 0–1.3 Mya and attribution to assembly gaps
- UBCS statistics used as a clock to infer evolutionary distances among Great Apes (chimpanzee, bonobo, gorilla, orangutan, gibbon)
- Divergence time ranges: chimpanzee ~4.7–6.5 Mya; bonobo ~4.3–5.8 Mya; gorilla ~6.6–9.9 Mya; orangutan ~12.5–18.4 Mya; gibbon ~20.7–29.6 Mya
- Fusion likely involved loss of telomeric/subtelomeric material and potential functional gene loss

QC result: Pass.

Skourtanioti E et al., Cell - This episode summarizes a population‑genomic analysis that models genetic outliers in ancient Eurasian samples, using PCA and admixture modeling to test source combinations and estimate ancestry proportions among Caucasus, steppe, and Central Asian groups. Key terms: ancient DNA, admixture, Caucasus, Sarmatian, population genomics.

Study Highlights:
The authors analyze ancient human genomes with PCA and admixture modelling to identify and model genetic outliers across the Caucasus, steppe and Central Asia. They report fitted admixture proportions for competing source models (examples in the text include values such as 55±8%/45±8% and 84±4%/16±4%). Models highlight contributions linked to Sarmatian/Kazakhstan-related sources and Antiquity–Medieval Georgia/Alanic-related ancestry in some samples. The study uses a large panel of coded samples and explicit model comparisons to evaluate best‑fit ancestry sources.

Conclusion:
Admixture modelling and PCA reveal multi‑source ancestry for genetic outliers in ancient Eurasia, with detectable Sarmatian/Kazakhstan and Caucasus/Georgian‑related components in the tested samples.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
MODELLINGOFGENETIC'OUTLIERS'

First author:
Skourtanioti E

Journal:
Cell

DOI:
10.1016/j.cell.2025.07.013

Reference:
Skourtanioti E., Jia X., Tavartkiladze N., Bitadze L., Shengelia R., Tushabramishvili N., et al.. The genetic history of the Southern Caucasus from the Bronze Age to the Early Middle Ages: 5,000 years of genetic continuity despite high mobility. Cell, 188, 5278-5294.e21. (2025). https://doi.org/10.1016/j.cell.2025.07.013

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/the-genetic-history-of-the-southern-caucasus-5-000-years-of-continuity-despite-high-mobility

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-09-20.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited transcript segments describing IBD/ROH analyses, continuity and Bronze Age admixture, urban–rural contrasts, ACD findings, and study limitations.
- transcript topics: Southern Caucasus geography and population history; IBD (identical by descent) and ROH (runs of homozygosity) metrics; Long-term local genetic continuity vs Bronze Age admixture; Rural isolation vs urban genetic diversity; Artificial cranial deformation (ACD) findings in medieval remains; Limitations and caveats (undersampling, radiocarbon dating margins)

QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 5
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- 230 ancient genomes from 50 sites spanning 3500 BCE to 700 CE
- IAD/ROH metrics used to infer relatedness and inbreeding
- Over 90% local genetic continuity across 5000 years
- Bronze Age influxes: northern steppe pastoralists and southern Anatolian populations
- Nedziki rural sites show 25-30% marriages between first/second cousins
- Semtavro urban cemetery shows high genetic diversity and distant outliers

QC result: Pass.

Richardson M et al., The American Journal of Human Genetics - An international HBOP Variant Curation Expert Panel developed PALB2-specific specifications of the 2015 ACMG/AMP variant-interpretation guidelines by tailoring, limiting, or removing existing codes and tested them on 39 pilot variants to improve ClinVar concordance and harmonize classification. Key terms: PALB2, ACMG/AMP, variant curation, HBOP VCEP, ClinVar.

Study Highlights:
The HBOP VCEP reviewed ACMG/AMP codes and advised against 13 codes, limited six, and tailored nine to PALB2-specific biology. They set conservative population thresholds (BA1 0.1%, BS1 0.01%) and refined PVS1/PVS1(RNA) application, defining Tyr1183 as a C-terminal boundary for loss-of-function evidence. A pilot curation of 39 variants produced concordant classifications for 31 of 37 ClinVar variants (84%) and led to reclassification of several VUS/conflicting entries. The recommendations are conservative and evidence-based to support harmonized PALB2 variant interpretation and clinical reporting.

Conclusion:
PALB2-specific ACMG/AMP specifications provide a conservative, evidence-based framework that improves harmonization and accuracy of variant classification, supporting ClinVar deposition and clinical management of carriers.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline PALB2 sequence variants

First author:
Richardson M

Journal:
The American Journal of Human Genetics

DOI:
10.1016/j.ajhg.2025.08.020

Reference:
Richardson M.E. et al., Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline PALB2 sequence variants. The American Journal of Human Genetics. 2025;112:1–15. https://doi.org/10.1016/j.ajhg.2025.08.020

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/specifications-of-the-acmg-amp-guidelines-for-palb2-variant-interpretation

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-09-19.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited the transcript sections on PALB2 biology, HBOPVCEP PALB2 specifications, ACMG/AMP code modifications, pilot study outcomes, missense/pathogenicity limitations, PVS1/Tyr1183 boundary, splicing guidance, VUS backlog, and the need for high-throughput functional assays.
- transcript topics: PALB2 role in homologous recombination repair; HBOPVCEP PALB2 specifications and code changes; Pilot study results and ClinVar concordance; VUS resolution outcomes; Missense pathogenicity limitations and splicing considerations; PVS1, Tyr1183 boundary and RNA splicing guidance

QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 7
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- HBOPVCEP PALB2 specifications exist and tailor/limit ACMG/AMP codes for PALB2
- Pilot with 39 PALB2 variants; 37 in ClinVar; 84% concordance with ClinVar classifications
- Among ClinVar VUS/conflicts (14), 4 variants resolved to benign or LP/Pathogenic
- Missense pathogenicity not established; restricted use of several missense-driven codes
- BA1 0.1% and BS1 0.01% population thresholds; PM2_Supporting used for rarity
- PVS1 and PVS1(RNA) weighting; Tyr1183 boundary; splicing predictions guide PVS1/RNA and BP7/BP7(RNA)

QC result: Pass.

Rivolta C et al., The American Journal of Human Genetics - RetiGene is an expert‑curated, openly accessible atlas integrating variant data, bulk and single‑cell RNA‑seq, and functional annotations for genes linked to inherited retinal diseases to aid diagnosis and research. Key terms: RetiGene, inherited retinal diseases, gene atlas, single-cell RNA-seq, diagnostic genetics.

Study Highlights:
The authors manually curated 470 genes (plus 4 loci) strongly associated with inherited retinal diseases and flagged 196 candidate genes and 17 discarded genes based on evidence strength. They integrated variant annotations, bulk (FANTOM5) and single‑cell RNA‑seq, and Gene Ontology‑based functional classifications to map genotype–phenotype relationships. Ciliary genes form the largest functional category and autosomal recessive inheritance predominates; expression patterns help explain syndromic versus non‑syndromic presentations. The resource is hosted at retigene.erdc.info and is intended for regular updates to support diagnostics, gene prioritization, and therapeutic development.

Conclusion:
RetiGene provides a continuously updated, expert‑curated gene atlas that integrates genetic and expression data to improve molecular diagnosis, panel design, and functional studies of inherited retinal diseases.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
RetiGene, a comprehensive gene atlas for inherited retinal diseases

First author:
Rivolta C

Journal:
The American Journal of Human Genetics

DOI:
10.1016/j.ajhg.2025.08.017

Reference:
Rivolta C., Celik E., Kamdar D., et al., RetiGene, a comprehensive gene atlas for inherited retinal diseases. The American Journal of Human Genetics (2025), https://doi.org/10.1016/j.ajhg.2025.08.017

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/retigene-a-comprehensive-gene-atlas-for-inherited-retinal-diseases

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-09-18.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Substantive auditing of the transcript sections describing the RetiGene atlas, gene counts (470 genes + 4 loci), functional categorization (with cilium as a leading category), inheritance patterns (68.9% AR), housekeeping paradox and tissue expression (retina-prevalent vs ubiquitous), RNA-seq and scRNA-seq findings, th
- transcript topics: Diagnostic challenges in inherited retinal diseases; RetiGene gene atlas and the 470 genes (plus 4 loci); Functional categorization of IRD genes (cilia, transmembrane transport, lipid metabolism); RNA-seq and single-cell RNA-seq expression patterns; Inheritance patterns and variant effects (LoF vs missense); Clinical impact: discarded genes (UNC119) and diagnostic panels

QC Summary:
- factual score: 8/10
- metadata score: 10/10
- supported core claims: 7
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- 470 IRD-related genes (including 4 loci) retained as strongly disease-associated
- 196 candidate genes and 17 excluded genes
- Cilium was the largest functional category, comprising 83 of the 466 curated genes (17.8%)
- Autosomal recessive (AR) inheritance accounts for 68.9% of curated genes (across syndromic and non-syndromic)
- 47.6% of non-syndromic IRD genes were retina-prevalent; 40.1% of retina-restricted genes were ubiquitously expressed
- Single-cell data showed rod/cone/RPE specificity patterns and tissue-specific expression relevant to phenotypes

QC Flagged Items (audited and not fully supported):
- Numeric claim uncertain: 470 genes (including four loci) retained as strongly disease-associated (and 4 loci).
- Numeric claim uncertain: Cilium category comprises 83 genes (17.8%) among 466 curated genes.
- Numeric claim uncertain: 68.9% AR inheritance across curated genes.
- Numeric claim uncertain: 47.6% retina-prevalent among non-syndromic IRD genes.

QC result: Warning. Items above were flagged during automated QC; the editorial team reviewed them before release.